Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Fong

Showing results (71-80 of 198) with videos related to

Pageof 20
Sort By:
The Oncologist|April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 StudyMark N Stein, Lawrence Fong, Ronald Tutrone, et al.
Urologic Oncology|October 2, 2010
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II studyTerence W Friedlander, Vivian K Weinberg, Eric J Small, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2024
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized PatientsMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of Immunological Methods|March 23, 2021
Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapyLi Zhang, Jason Cham, James Cooley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced HepatitisMichael Li, Danny Wong, Jordan S Sack, et al.
The Journal of Experimental Medicine|April 23, 2014
Enhancement of an anti-tumor immune response by transient blockade of central T cell toleranceImran S Khan, Maria L Mouchess, Meng-Lei Zhu, et al.
Clinical Pediatrics|May 16, 2017
Television During Meals in the First 4 Years of LifeLindsay M Thimmig, Michael D Cabana, Michael G Bentz, et al.
Frontiers in Immunology|September 2, 2024
E-cigarette exposure disrupts antitumor immunity and promotes metastasisMarcel Arias-Badia, Chien-Chun Steven Pai, PeiXi Chen, et al.
Cancer|March 10, 2011
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinomaAndrea L Harzstark, Eric J Small, Vivian K Weinberg, et al.
The Journal of Experimental Medicine|November 23, 2006
Spontaneous autoimmunity prevented by thymic expression of a single self-antigenJason DeVoss, Yafei Hou, Kellsey Johannes, et al.
Pageof 20

Showing results (71-80 of 198) with videos related to

Sort By:
Pageof 20
The Oncologist|April 4, 2022
ADXS31142 Immunotherapy ± Pembrolizumab Treatment for Metastatic Castration-Resistant Prostate Cancer: Open-Label Phase I/II KEYNOTE-046 StudyMark N Stein, Lawrence Fong, Ronald Tutrone, et al.
Urologic Oncology|October 2, 2010
Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II studyTerence W Friedlander, Vivian K Weinberg, Eric J Small, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2024
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized PatientsMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of Immunological Methods|March 23, 2021
Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapyLi Zhang, Jason Cham, James Cooley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced HepatitisMichael Li, Danny Wong, Jordan S Sack, et al.
The Journal of Experimental Medicine|April 23, 2014
Enhancement of an anti-tumor immune response by transient blockade of central T cell toleranceImran S Khan, Maria L Mouchess, Meng-Lei Zhu, et al.
Clinical Pediatrics|May 16, 2017
Television During Meals in the First 4 Years of LifeLindsay M Thimmig, Michael D Cabana, Michael G Bentz, et al.
Frontiers in Immunology|September 2, 2024
E-cigarette exposure disrupts antitumor immunity and promotes metastasisMarcel Arias-Badia, Chien-Chun Steven Pai, PeiXi Chen, et al.
Cancer|March 10, 2011
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinomaAndrea L Harzstark, Eric J Small, Vivian K Weinberg, et al.
The Journal of Experimental Medicine|November 23, 2006
Spontaneous autoimmunity prevented by thymic expression of a single self-antigenJason DeVoss, Yafei Hou, Kellsey Johannes, et al.
Pageof 20